I still vividly remember the first time we observed neurons responding not to audible sound, but to concentrated, precisely calibrated ultrasonic pulses. On the screen in front of us, calcium signals from brain cells began ...
Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates. ...
19 minutes ago
0
0
People from the Outer Hebrides and north-west Ireland have the highest risk of developing a genetic disease that causes a dangerous build-up of iron in the body, a study published in the journal Nature Communications suggests.
1 hour ago
0
0
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers ...
4 hours ago
0
21
Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for female sexual dysfunction. ...
1 hour ago
0
0
Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in magic mushrooms, produces subtle but distinct effects on social behavior and inflammation that depend ...
5 hours ago
0
23
Africa's health future hinges on its ability to finance and commercialize its own medical innovations, rather than rely on increasingly uncertain international funding, African science leaders have warned. In a commentary ...
6 hours ago
0
0
"By cleverly combining new techniques for analyzing DNA at the level of individual molecules, we can achieve real breakthroughs in research into conditions such as dementia," predicts Professor John van Noort. Together with ...
5 hours ago
0
0
Results from a pilot clinical trial evaluating the safety and feasibility of repeated focused ultrasound-induced blood–brain barrier (BBB) opening combined with the monoclonal antibody drug Avastin (bevacizumab) in patients ...
6 hours ago
0
0
Every three seconds, someone, somewhere in the world, develops dementia. The number of people living with the condition is projected to rise dramatically, doubling from 78 million in 2020 to 139 million by 2050, making dementia ...
